Data Information and Disclaimers
The locations displayed above have received an order of Paxlovid or Lagevrio (molnupiravir) in the last two months and/or have reported availability of the oral antiviral medications within the last two weeks. Those sites that have not reported in the last two weeks display a notification with the site details, "Inventory has not been reported in the last 2 weeks. Please contact the provider to make sure the product is available."

All therapeutics identified in the locator must be used in alignment with the terms of the respective product’s EUA. Data displayed on this page is for informational purposes only. The data on this page is for locations with the oral antivirals Pfizer's Paxlovid and Merck's Lagevrio (molnupiravir). Visit COVID-19 Treatments and Therapeutics for more information on all treatment options.

The medication is provided at no cost. Some sites may charge for services not covered by insurance. Some sites may offer telehealth services. This website is intended for informational purposes only and does not serve as an endorsement or recommendation for use of any of the locations listed on the sites.

Clarification for DoD Facilities: Those individuals eligible for care in an MTF include Active Duty Service Members (ADSMs), covered beneficiaries enrolled in TRICARE Prime or Select, including TRICARE Reserve Select (TRS), TRICARE Retired Reserve (TRR) and TRICARE Young Adult (TYA) participants, TRICARE for Life beneficiaries, and individuals otherwise entitled by law to MTF care (e.g., regular retired members and their dependents who are not enrolled in TRICARE but who are otherwise eligible for MTF space-available care, certain foreign military members and their families registered in DEERS, and others).

As shown on the summary table, HHS’ contingency plans for agency operations in the absence of appropriations will lead to retaining 51,901 staff and furloughing 35,074 staff as of day two of a funding hiatus. Put another way, 60% of HHS employees will be retained and 40% will be furloughed. These percentages vary among HHS Operating Divisions and offices. Operating Divisions with a substantial direct service component will have more of their staff retained. For example, the NIH Clinical Center will continue to care for patients and admit new patients for whom it is medically necessary. FDA will continue core functions to handle and respond to emergencies – such as monitoring for and quickly responding to outbreaks related to foodborne illness and the flu, supporting food and medical product recalls when products endanger consumers and patients, pursuing criminal and certain civil investigations when we believe public health is at risk, screening the food and medical products that are imported to the U.S. to protect consumers and patients from harmful products, and addressing other critical public health issues.

Locations of COVID-19 Test to Treat sites. Dataset only includes locations for Paxlovid (Antiviral) and Lagevrio (molnupiravir). COVID-19 therapeutics require a prescription to obtain.

Locations of publicly available COVID-19 Therapeutics. Dataset only includes locations for Evusheld (monoclonal antibody), Molnupiravir (antiviral), and Paxlovid (Antiviral). COVID-19 therapeutics require a prescription to obtain. Limitations: public contact information.

On 1/3/2022 - The following changes were made to this dataset.
- Dropped the Expected Deliver Date column - This was a derived field set to 3 days after the Last Order Date field.
- Added the following fields
Last Date Delivered
Total Courses
Courses Available
Courses Available Date

On 1/4/2022 - Added Geocoded Address

On 1/11/2022 - Added NPI - National Provider Identifier

As shown on the summary table, HHS’ contingency plans for agency operations in the absence of appropriations will lead to retaining 51,901 staff and furloughing 35,074 staff as of day two of a funding hiatus. Put another way, 60% of HHS employees will be retained and 40% will be furloughed. These percentages vary among HHS Operating Divisions and offices. Operating Divisions with a substantial direct service component will have more of their staff retained. For example, the NIH Clinical Center will continue to care for patients and admit new patients for whom it is medically necessary. FDA will continue core functions to handle and respond to emergencies – such as monitoring for and quickly responding to outbreaks related to foodborne illness and the flu, supporting food and medical product recalls when products endanger consumers and patients, pursuing criminal and certain civil investigations when we believe public health is at risk, screening the food and medical products that are imported to the U.S. to protect consumers and patients from harmful products, and addressing other critical public health issues.

Footnote in data
1/ This categorization does not reflect the total number of Commission Corps personnel at HHS, which is 3,949 total staff among all HHS operating and staff divisions.

This data represents unaccompanied children who are taken into custody by Customs and Border Protection brought to a facility and processed for transfer to the Department of Health and Human Services (HHS) as required by law. HHS holds the child for testing and quarantine, and shelters the child until the child is placed with a sponsor here in the United States.

This data represents unaccompanied children who are taken into custody by Customs and Border Protection brought to a facility and processed for transfer to the Department of Health and Human Services (HHS) as required by law. HHS holds the child for testing and quarantine, and shelters the child until the child is placed with a sponsor here in the United States.

The 2020-2021 School Learning Modalities dataset provides weekly estimates of school learning modality (including in-person, remote, or hybrid learning) for U.S. K-12 public and independent charter school districts for the 2020-2021 school year, from August 2020 – June 2021.

These data were modeled using multiple sources of input data (see below) to infer the most likely learning modality of a school district for a given week. These data should be considered district-level estimates and may not always reflect true learning modality, particularly for districts in which data are unavailable. If a district reports multiple modality types within the same week, the modality offered for the majority of those days is reflected in the weekly estimate. All school district metadata are sourced from the National Center for Educational Statistics (NCES) for 2020-2021.

School learning modality types are defined as follows:

• In-Person: All schools within the district offer face-to-face instruction 5 days per week to all students at all available grade levels.


• Remote: Schools within the district do not offer face-to-face instruction; all learning is conducted online/remotely to all students at all available grade levels.


• Hybrid: Schools within the district offer a combination of in-person and remote learning; face-to-face instruction is offered less than 5 days per week, or only to a subset of students.

Data Information

• School learning modality data provided here are model estimates using combined input data and are not guaranteed to be 100% accurate. This learning modality dataset was generated by combining data from four different sources: Burbio [1], MCH Strategic Data [2], the AEI/Return to Learn Tracker [3], and state dashboards [4-20]. These data were combined using a Hidden Markov model which infers the sequence of learning modalities (In-Person, Hybrid, or Remote) for each district that is most likely to produce the modalities reported by these sources. This model was trained using data from the 2020-2021 school year. Metadata describing the location, number of schools and number of students in each district comes from NCES [21].


• You can read more about the model in the CDC MMWR: COVID-19–Related School Closures and Learning Modality Changes — United States, August 1–September 17, 2021.


• The metrics listed for each school learning modality reflect totals by district and the number of enrolled students per district for which data are available. School districts represented here exclude private schools and include the following NCES subtypes:
  
  
  
  • Public school district that is NOT a component of a supervisory union
  
  
  • Public school district that is a component of a supervisory union
  
  
  • Independent charter district
  
  
  
  


• “BI” in the state column refers to school districts funded by the Bureau of Indian Education.

Technical Notes

• Data from September 1, 2020 to June 25, 2021 correspond to the 2020-2021 school year. During this timeframe, all four sources of data were available. Inferred modalities with a probability below 0.75 were deemed inconclusive and were omitted.


• Data for the month of July may show “In Person” status although most school districts are effectively closed during this time for summer break. Users may wish to exclude July data from use for this reason where applicable.

Sources

1. K-12 School Opening Tracker. Burbio 2021; https

The 2021-2022 School Learning Modalities dataset provides weekly estimates of school learning modality (including in-person, remote, or hybrid learning) for U.S. K-12 public and independent charter school districts for the 2021-2022 school year and the Fall 2022 semester, from August 2021 – December 2022.

These data were modeled using multiple sources of input data (see below) to infer the most likely learning modality of a school district for a given week. These data should be considered district-level estimates and may not always reflect true learning modality, particularly for districts in which data are unavailable. If a district reports multiple modality types within the same week, the modality offered for the majority of those days is reflected in the weekly estimate. All school district metadata are sourced from the National Center for Educational Statistics (NCES) for 2020-2021.

School learning modality types are defined as follows:

• In-Person: All schools within the district offer face-to-face instruction 5 days per week to all students at all available grade levels.


• Remote: Schools within the district do not offer face-to-face instruction; all learning is conducted online/remotely to all students at all available grade levels.


• Hybrid: Schools within the district offer a combination of in-person and remote learning; face-to-face instruction is offered less than 5 days per week, or only to a subset of students.

Data Information

• School learning modality data provided here are model estimates using combined input data and are not guaranteed to be 100% accurate. This learning modality dataset was generated by combining data from four different sources: Burbio [1], MCH Strategic Data [2], the AEI/Return to Learn Tracker [3], and state dashboards [4-20]. These data were combined using a Hidden Markov model which infers the sequence of learning modalities (In-Person, Hybrid, or Remote) for each district that is most likely to produce the modalities reported by these sources. This model was trained using data from the 2020-2021 school year. Metadata describing the location, number of schools and number of students in each district comes from NCES [21].


• You can read more about the model in the CDC MMWR: COVID-19–Related School Closures and Learning Modality Changes — United States, August 1–September 17, 2021.


• The metrics listed for each school learning modality reflect totals by district and the number of enrolled students per district for which data are available. School districts represented here exclude private schools and include the following NCES subtypes:
  
  
  
  • Public school district that is NOT a component of a supervisory union
  
  
  • Public school district that is a component of a supervisory union
  
  
  • Independent charter district
  
  
  
  


• “BI” in the state column refers to school districts funded by the Bureau of Indian Education.

Technical Notes

• Data from August 1, 2021 to June 24, 2022 correspond to the 2021-2022 school year. During this time frame, data from the AEI/Return to Learn Tracker and most state dashboards were not available. Inferred modalities with a probability below 0.6 were deemed inconclusive and were omitted. During the Fall 2022 semester, modalities for districts with a school closure reported by Burbio were updated to either “Remote”, if the closure spanned the entire week, or “Hybrid”, if the closure spanned 1-4 days of the week.


• Data from August

This time series dataset includes viral COVID-19 laboratory test [Polymerase chain reaction (PCR)] results from over 1,000 U.S. laboratories and testing locations including commercial and reference laboratories, public health laboratories, hospital laboratories, and other testing locations. Data are reported to state and jurisdictional health departments in accordance with applicable state or local law and in accordance with the Coronavirus Aid, Relief, and Economic Security (CARES) Act (CARES Act Section 18115).

Data are provisional and subject to change.

Data presented here is representative of diagnostic specimens being tested - not individual people - and excludes serology tests where possible. Data presented might not represent the most current counts for the most recent 3 days due to the time it takes to report testing information. The data may also not include results from all potential testing sites within the jurisdiction (e.g., non-laboratory or point of care test sites) and therefore reflect the majority, but not all, of COVID-19 testing being conducted in the United States.

Sources: CDC COVID-19 Electronic Laboratory Reporting (CELR), Commercial Laboratories, State Public Health Labs, In-House Hospital Labs

Data for each state is sourced from either data submitted directly by the state health department via COVID-19 electronic laboratory reporting (CELR), or a combination of commercial labs, public health labs, and in-house hospital labs. Data is taken from CELR for states that either submit line level data or submit aggregate counts which do not include serology tests.